David P. Hochman, Director at Corbus Pharmaceuticals Holdings, Inc. (CRBP), bought 10,000 shares at $7.08 ($71K) on 2017-11-10, disclosed to the SEC on 2017-11-13.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| Filing → |
| OBIO | BUY | 2026-05-19 | $19K | — | Filing → |
| OBIO | BUY | 2026-03-16 | $43K | — | Filing → |
| OBIO | BUY | 2025-11-17 | $20K | — | Filing → |